4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
NSJBioreagents(授权代理)
主营:肿瘤,肿瘤生物标志物,细胞凋亡,免疫学,细胞生物学和转录因子
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > > NSJ Bio/CD31 Antibody / PECAM-1 [clone PECAM1/4341] (V4043)/100 ug/V4043SAF-100UG
商品详细NSJ Bio/CD31 Antibody / PECAM-1 [clone PECAM1/4341] (V4043)/100 ug/V4043SAF-100UG
NSJ Bio/CD31 Antibody / PECAM-1 [clone PECAM1/4341] (V4043)/100 ug/V4043SAF-100UG
NSJ Bio/CD31 Antibody / PECAM-1 [clone PECAM1/4341] (V4043)/100 ug/V4043SAF-100UG
商品编号: V4043SAF-100UG
品牌: NSJBioreagents
市场价: ¥9980.00
美元价: 7984.00
产地: 美国(厂家直采)
公司:
产品分类: 其他
公司分类:
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Description

CD31 (PECAM-1) is a transmembrane glycoprotein member of the immunoglobulin supergene family of adhesion molecules. CD31 is expressed by stem cells of the hematopoietic system and is primarily used to identify and concentrate these cells for experimental studies as well as for bone marrow transplantation. Anti-CD31 has shown to be highly specific and sensitive for vascular endothelial cells. Staining of nonvascular tumors (excluding hematopoietic neoplasms) is rare. CD31 MAb reacts with normal, benign, and malignant endothelial cells which make up blood vessel lining. The level of CD31 expression can help to determine the degree of tumor angiogenesis, and a high level of CD31 expression may imply a rapidly growing tumor and potentially a predictor of tumor recurrence.

Application Notes

Optimal dilution of the CD31 antibody should be determined by the researcher.

Immunogen

A portion of amino acids 1-350 from the human protein was used as the immunogen for the CD31 antibody.

Storage

Aliquot the CD31 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

品牌介绍
NSJ Bioreagents已有20多年的历史。 NSJ Bio提供领先的、广泛使用的单克隆抗体以及单克隆和多克隆抗体的所有领域的研究,包括肿瘤,肿瘤生物标志物,细胞凋亡,免疫学,细胞生物学和转录因子。产品提供多种规格,以更好地适应研究人员的测试需求和预算限制。   链接:http://www.nsjbio.com/ 温馨提示:不可用于临床治疗。 风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。